Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.65
+0.16 (2.47%)
Mar 19, 2026, 11:19 AM EDT - Market open
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 485 employees as of December 31, 2025. The number of employees decreased by 349 or -41.85% compared to the previous year.
Employees
485
Change (1Y)
-349
Growth (1Y)
-41.85%
Revenue / Employee
$350,835
Profits / Employee
-$644,872
Market Cap
391.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 485 | -349 | -41.85% |
| Dec 31, 2024 | 834 | -384 | -31.53% |
| Dec 31, 2023 | 1,218 | -74 | -5.73% |
| Dec 31, 2022 | 1,292 | 651 | 101.56% |
| Dec 31, 2021 | 641 | 146 | 29.49% |
| Mar 31, 2021 | 495 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Century Therapeutics | 150 |
| Enanta Pharmaceuticals | 120 |
| Lineage Cell Therapeutics | 77 |
| PureTech Health | 56 |
| Candel Therapeutics | 55 |
| Anavex Life Sciences | 34 |
| Benitec Biopharma | 19 |
DNA News
- 17 days ago - Ginkgo Bioworks Makes Major Pivot - Seeking Alpha
- 17 days ago - Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - PRNewsWire
- 19 days ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter - Benzinga
- 20 days ago - Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - PRNewsWire
- 4 weeks ago - Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - PRNewsWire
- 4 weeks ago - Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark - PRNewsWire